Get 15% Off on Memorial Day Sitewide Sale Get 15% Off on Memorial Day Sitewide Sale

ADVERTISEMENT

All Wrong About Alzheimer's

Analysis by Dr. Joseph Mercola Fact Checked

alzheimer's medications

Story at-a-glance -

  • Drug development for Alzheimer’s has so far been a dismal failure, with 300 failed trials to date
  • In a study of the experimental Alzheimer’s drugs gantenerumab and solanezumab, they failed to slow cognitive decline after an average of five years
  • The drugs were intended to remove beta-amyloid from the brain, but beta-amyloid is a symptom of Alzheimer’s — not the cause
  • Bredesen’s ReCODE protocol evaluates 150 factors, including biochemistry, genetics and historical imaging, known to contribute to Alzheimer’s disease
  • Bredesen has published a case report of 100 patients using the ReCODE protocol, in which all show sustained improvement in symptoms

Alzheimer’s disease, a condition characterized by an accumulation of beta-amyloid plaques and neurofibrillary tangles in the brain, affects an estimated 5 million Americans; this number is expected to reach 14 million by 2060. With no known cure, researchers are scrambling to find treatments, often with a misguided focus on drugs designed to remove excess beta-amyloid in the brain.

Drug development for Alzheimer’s has so far been a dismal failure, with 300 failed trials to date. Despite the history of letdowns, the latest failed drug trial is still making waves in the research community because there were high hopes that it would provide a breakthrough treatment for people with gene mutations known to cause Alzheimer’s.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and will soon be blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy